All products are batch-tested by an independent third-party laboratory (purity documented on the CoA
Mounjaro and Zepbound generated $10.1 billion combined in Q3 2025, surpassing Mercks Keytruda to become the highestgrossing drug franchise globally
Additionally, 48% of participants had hypertension and 37% had dyslipidemia at baseline defined by medical history questioning
Use of GLP-1 analogue drugs is associated with benefits but also health risks The use of glucagon-like peptide-1 receptor agonists (GLP-1RAs), used to treat diabetes and obesity, may be associated with a wide range of health effects, both positive - such as a reduced risk of cardiometabolic disorders - and negative - an increased risk of gastrointestinal conditions or hypertension
The following information is biased by the CDC
Ongoing Care and Support : After approval, you're supported by 24/7 care coordination including appointment reminders, prescription updates and refills, pharmacy services, and direct interaction with our care team to address your treatment plan concerns and adjustments